Skip to main content

Table 1 Characteristics of obese patients and controls

From: The Pro12Ala polymorphism in the PPAR-γ2 gene is not associated to obesity and type 2 diabetes mellitus in a Cameroonian population

Parameters

Cases (n = 62)

Controls (n = 60)

p value

Age (years)

43 (11)

34 (12)

<0.001

BMI (Kg/m2)

34.22 (4.62)

22.10 (1.70)

<0.001

WHR

0.86 (0.07)

0.81 (0.06)

<0.001

FPG (mg/dL)

96.81 (11.74)

92.03 (11.08)

0.027

SBP (mmHg)

131.13 (20.05)

116.98 (16.45)

<0.001

DBP (mmHg)

80.53 (10.90)

70.77 (10.97)

<0.001

T-C (mg/L)

190.5 (35.89)

180.68 (26.85)

0.040

TG (mg/dL)

135.79 (19.47)

131.81 (18.26)

0.247

HDL-C (mg/dL)

49.02 (7.89)

47.89 (5.37)

0.360

LDL-C (mg/dL)

114.84 (33.29)

106.46 (25.02)

0.119

AI

3.93 (0.68)

3.80 (0.62)

0.293

  1. Data are expressed as mean (standard deviation)
  2. FPG Fasting Plasma Glucose, SBP Systolic Blood Pressure, DBP Diastolic Blood Pressure, HDL-C high density lipoprotein cholesterol, LDL-C low density lipoprotein cholesterol, TG triglycerides, AI Atherogenic index = total cholesterol/HDL-cholesterol